The injection of recombinant TRAIL significantly reduced cardiac fibrosis and apoptosis and, as consequence, prevented more relevant cardiac structural changes in a mouse model of cardiomyopathy [13]. The gene discussed is TNFSF10; the disease is fibrosis.